This CMEO BriefCase will discuss the mental health care challenges of a 28-year-old Black male, with a history of schizophrenia and previous failed attempts at treatment.
Javeed Sukhera, MD, PhD, FRCPC, is the Chair of Psychiatry at the Institute of Living and Chief of the Department of Psychiatry at Hartford Hospital in Hartford, Connecticut. He is also an Associate Clinical Professor in the Department of Psychiatry at the Yale School of Medicine. Dr. Sukhera comes to Hartford HealthCare from Western University in London, Ontario, Canada, where he held various clinical and academic leadership roles.
Dr. Sukhera graduated from the University of Toronto and Ben-Gurion University and completed his residency and child/adolescent fellowship training at the University of Rochester in Rochester, New York. He completed his PhD in Health Professions Education from Maastricht University in Maastricht, Netherlands. He is an internationally recognized health professions education researcher. His research program explores novel approaches to addressing stigma and bias among health professionals, and he has also been involved in advocacy and cross-sectoral work in education, policing, and community services. He is a member of the Editorial Advisory Board of the Canadian Medical Association Journal (CMAJ) and Deputy Editor of Perspectives on Medical Education.
Wendy Oliver-Pyatt, MD, FAED, CEDS is the co-founder, Chief Executive Officer (CEO) and Chief Clinical Officer of Within Health and the CEO and co-founder of Galen Hope and BrightQuest programs operating through Galen Mental Health. She is a board-certified psychiatrist and world-leading expert on treating eating disorders with more than 25 years of clinical experience. She has developed five separate treatment programs all grounded in a strong bio-psycho-social foundation and incorporating intensive psychotherapy with behavioral foundations and high medical standards. Dr. Oliver-Pyatt is known for her innovative, humane, and dignity-enhancing approach to medically and psychiatrically thorough care. She has developed a unique treatment approach that delves into the underlying issues that place a person at risk for mental health conditions and eating disorders, leading to healing, health, and inner peace.
Dr. Oliver-Pyatt received her specialty training at New York University-NYC Health + Hospitals/Bellevue and has held faculty positions at New York University, Albert Einstein School of Medicine, and University of Nevada School of Medicine where she first developed her passion as a mentor and educator. She is a Fellow of the Academy for Eating Disorders and the International Association of Eating Disorder Professionals, has served on the Joint Commission’s Advisory Committee, and has received U.S. Senatorial Recognition for her commitment to the mental health treatment community.
Described by colleagues as warm and wise, Dr. Oliver-Pyatt matches her comprehensive training with an unwavering belief in compassionate and scientifically sound treatment.
Monica Peek, MD, MPH, MSc is an Ellen H. Block Professor of Health Justice in the Department of Medicine. She is also the Associate Director, Chicago Center for Diabetes Translation Research, and Director of Research, MacLean Center for Clinical Medical Ethics. She is a practicing internist, medical educator, and clinician investigator. Her research pursues health equity and social justice, with a focus on promoting equitable doctor/patient relationships among racial minorities, integrating the medical and social needs of patients, and addressing health care discrimination and structural racism impacting health outcomes (e.g., diabetes, COVID-19). Dr. Peek has authored more than 200 peer-reviewed publications and abstracts on health care disparities, diversity, and bias; has been the principal investigator of multiple grants to address health disparities; and has been invited to speak at numerous local and national medical meetings.
In this fourth and final installment of a REMS BriefCase series on pain management faculty will discuss the importance of recognizing the signs of OUD and how to intervene if red flags do appear.
Dr. Sudheer Potru is a triple-board-certified anesthesiologist, interventional pain physician, and addiction medicine specialist with a strong interest in both opioid safety and addiction. A Fellow of the American Society of Addiction Medicine, he is also the medical director of the Atlanta VA’s complex pain clinic, which specializes in treating veterans who have chronic pain associated with high-dose opioid use or substance abuse problems. He founded The American Society of Regional Anesthesia and Pain Medicine?s (ASRA) Pain and Substance Use Disorder Special Interest Group (SIG) in 2019, sits on multiple national committees related to pain and substance use disorders, and is passionate about teaching other clinicians about diagnosis and treatment of substance use disorders as well as research and advocacy related to these topics.
Dr. Melissa B. Weimer, DO, MCR, FASAM, is an Associate Professor of Medicine and Public Health at Yale School of Medicine and Yale School of Public Health. She is a clinician-educator who is board certified in both Internal Medicine and Addiction Medicine. She is the Director of the Yale Addiction Medicine Consult Service at Yale New Haven Hospital and Associate Program Director for the Yale Addiction Medicine Fellowship program. Dr. Weimer has a clinical and research focus on improving the care of patients with addiction and its associated comorbidities, particularly in the hospital setting, and has specialty expertise in the treatment of complex pain. She is also passionate about expanding the workforce of healthcare professionals who can treat individuals with substance use disorders.
In this second installment of a REMS BriefCase series on pain management, faculty will discuss the CDC Guideline updates and how to successfully implement them
Dr. Melissa B. Weimer, DO, MCR, FASAM, is an Associate Professor of Medicine and Public Health at Yale School of Medicine and Yale School of Public Health. She is a clinician-educator who is board certified in both Internal Medicine and Addiction Medicine. She is the Director of the Yale Addiction Medicine Consult Service at Yale New Haven Hospital and Associate Program Director for the Yale Addiction Medicine Fellowship program. Dr. Weimer has a clinical and research focus on improving the care of patients with addiction and its associated comorbidities, particularly in the hospital setting, and has specialty expertise in the treatment of complex pain. She is also passionate about expanding the workforce of healthcare professionals who can treat individuals with substance use disorders.
In this third installment of a REMS BriefCase series on pain management, expert faculty will discuss why patient education is vital to creating safe and effective, multimodal treatment plans.
Dr. Lynn Kohan is a Professor of Anesthesiology and Pain Medicine. She graduated medical school and completed her anesthesiology residency at Georgetown University. Dr. Kohan completed her chronic pain fellowship at the University of Virginia and stayed on as faculty. She serves as the PD of the fellowship as well as the Division Chief. She is the membership chair of American Society of Regional Anesthesia (ASRA) Pain Medicine and serves on numerous other committees within the field of pain medicine. Additionally, Dr. Kohan serves on the editorial board of several pain medicine journals.
Dr. Melissa B. Weimer, DO, MCR, FASAM, is an Associate Professor of Medicine and Public Health at Yale School of Medicine and Yale School of Public Health. She is a clinician-educator who is board certified in both Internal Medicine and Addiction Medicine. She is the Director of the Yale Addiction Medicine Consult Service at Yale New Haven Hospital and Associate Program Director for the Yale Addiction Medicine Fellowship program. Dr. Weimer has a clinical and research focus on improving the care of patients with addiction and its associated comorbidities, particularly in the hospital setting, and has specialty expertise in the treatment of complex pain. She is also passionate about expanding the workforce of healthcare professionals who can treat individuals with substance use disorders.
In this CMEO BriefCase, a faculty expert will guide learners through a patient case scenario reflecting the impact of biases, disparities, and health inequities that reduce the quality of oncology care for racial and ethnic underserved patients with lung cancer.
Dr. Ana Velázquez Mañana is a thoracic oncologist and Assistant Professor of Medicine in the University of California, San Francisco (UCSF) Division of Hematology/Oncology at Zuckerberg San Francisco General Hospital in California. As a Latina, she advocates for workforce diversity and gender equity and has been named the Assistant Director of Diversity, Equity, Inclusion, and Accessibility for Training of the Helen Diller Family Comprehensive Cancer Center at UCSF. Dr. Velázquez completed her MD at the University of Puerto Rico School of Medicine, a Master of Biomedical Science at Mayo Clinic Graduate School of Biomedical Sciences (formerly known as Mayo Graduate School), and her Internal Medicine residency at Mount Sinai Beth Israel, where she was a Chief Resident. She joined UCSF in 2018, where she completed her clinical fellowship in Medical Oncology and postdoctoral research fellowship in the National Clinician Scholars Program.
Dr. Velázquez is a member of the prestigious John A. Watson Faculty Scholars Class of 2022 at UCSF and has been awarded a Conquer Cancer Foundation Young Investigator Award. She aims to support and improve the outcomes of patients with lung cancer from vulnerable backgrounds using health services and disparities research.
Edith Peterson Mitchell, MD, MACP, FCPP, FRCP, is board certified in Internal Medicine and Medical Oncology and is Clinical Professor of Medicine and Medical Oncology at Sidney Kimmel Medical College at Thomas Jefferson University and Associate Director for Diversity Programs and Director of the Center to Eliminate Cancer Disparities for Sidney Kimmel Cancer Center at Jefferson.
Dr. Mitchell has spent her medical career helping individuals in medically underserved areas and has demonstrated the importance of community service and outreach, especially to underserved populations. Her research in breast, colorectal, and pancreatic cancers and other GI malignancies involves new drug evaluation and chemotherapy, development of new therapeutic regimens, chemoradiation strategies for combined-modality therapy, patient selection criteria, and supportive care for patients with gastrointestinal cancer.
Dr. Mitchell served as the 116th President of the National Medical Association, and is a member of the American Medical Association, National Medical Association, Aerospace Medical Association, Association of Military Surgeons, Medical Society of Eastern Pennsylvania, ECOG/ACRIN Cancer Research Group, and Radiation Therapy Oncology Group. Because of her experience in the cancer research community, Dr. Mitchell served as a member of the National Cancer Institute Blue Ribbon Panel convened to advise the National Cancer Advisory Board on then Vice President Biden’s National Cancer Moonshot Initiative. In 2019, Dr. Mitchell began service as a member of the President’s Cancer Panel. In 2020, she became a Fellow of the Royal College of Physicians.
In addition to her medical achievements, Dr. Mitchell is a retired United States Air Force Brigadier General.
Join a faculty expert as they guide learners through a patient case scenario reflective of the impact of biases, disparities, and health inequities that reduce the quality of oncology care for racial and ethnic underserved patients with melanoma.
Susan C. Taylor, MD, FAAD is a Harvard, Columbia, and University of Pennsylvania educated physician and is the Bernett L. Johnson Jr. Endowed Professor of Dermatology at the University of Pennsylvania’s Perelman School of Medicine in Philadelphia. Dr. Taylor has performed pioneering work establishing Skin of Color as a sub-specialty within Dermatology. Her work has focused on advancing clinical knowledge and addressing gaps in research and education regarding skin of color populations. She has led education, policy, and research initiatives that have invigorated a national dialogue about diversity, health disparities, and skin of color related issues.
Dr. Taylor’s clinical focus encompasses disorders that uniquely or disproportionately affect patients of color including alopecia and pigmentary disorders, cosmetic and appearance enhancing devices, and cultural competency. She serves as Principal Investigator for Phase II through Phase IV clinical research trials. Dr. Taylor has over 75 original publications and has co-edited two major dermatology textbooks.
Dr. Taylor is the Past Vice President of the American Academy of Dermatology, founder of the Skin of Color Society, and a Board Member of the Women’s Dermatology Society.
Edith Peterson Mitchell, MD, MACP, FCPP, FRCP, is board certified in Internal Medicine and Medical Oncology and is Clinical Professor of Medicine and Medical Oncology at Sidney Kimmel Medical College at Thomas Jefferson University and Associate Director for Diversity Programs and Director of the Center to Eliminate Cancer Disparities for Sidney Kimmel Cancer Center at Jefferson.
Dr. Mitchell has spent her medical career helping individuals in medically underserved areas and has demonstrated the importance of community service and outreach, especially to underserved populations. Her research in breast, colorectal, and pancreatic cancers and other GI malignancies involves new drug evaluation and chemotherapy, development of new therapeutic regimens, chemoradiation strategies for combined-modality therapy, patient selection criteria, and supportive care for patients with gastrointestinal cancer.
Dr. Mitchell served as the 116th President of the National Medical Association, and is a member of the American Medical Association, National Medical Association, Aerospace Medical Association, Association of Military Surgeons, Medical Society of Eastern Pennsylvania, ECOG/ACRIN Cancer Research Group, and Radiation Therapy Oncology Group. Because of her experience in the cancer research community, Dr. Mitchell served as a member of the National Cancer Institute Blue Ribbon Panel convened to advise the National Cancer Advisory Board on then Vice President Biden’s National Cancer Moonshot Initiative. In 2019, Dr. Mitchell began service as a member of the President’s Cancer Panel. In 2020, she became a Fellow of the Royal College of Physicians.
In addition to her medical achievements, Dr. Mitchell is a retired United States Air Force Brigadier General.